qTICI: Quantitative assessment of brain tissue reperfusion on digital subtraction angiograms of acute ischemic stroke patients by Prasetya, H. (Haryadi) et al.
Research
qTICI: Quantitative assessment of
brain tissue reperfusion on digital
subtraction angiograms of acute
ischemic stroke patients
Haryadi Prasetya1,* , Lucas A Ramos1,*, Thabiso Epema1,
Kilian M Treurniet2, Bart J Emmer2, Ido R van den Wijngaard3,4,
Guang Zhang2, Manon Kappelhof2 , Olvert A Berkhemer2,5,6,7,
Albert J Yoo8, Yvo BEWM Roos9, Robert J van Oostenbrugge10,
Diederik WJ Dippel7, Wim H van Zwam5, Aad van der Lugt6,
Bas AJM de Mol11, Charles BLM Majoie2, Ed van Bavel1 and
Henk A Marquering1,2; on behalf of the MR CLEAN
Registry Investigators
Abstract
Background: The Thrombolysis in Cerebral Infarction (TICI) scale is an important outcome measure to evaluate the
quality of endovascular stroke therapy. The TICI scale is ordinal and observer-dependent, which may result in suboptimal
prediction of patient outcome and inconsistent reperfusion grading.
Aims: We present a semi-automated quantitative reperfusion measure (quantified TICI (qTICI)) using image processing
techniques based on the TICI methodology.
Methods: We included patients with an intracranial proximal large vessel occlusion with complete, good quality runs of
anteroposterior and lateral digital subtraction angiography from the MR CLEAN Registry. For each vessel occlusion, we
identified the target downstream territory and automatically segmented the reperfused area in the target downstream
territory on final digital subtraction angiography. qTICI was defined as the percentage of reperfused area in target
downstream territory. The value of qTICI and extended TICI (eTICI) in predicting favorable functional outcome
(modified Rankin Scale 0–2) was compared using area under receiver operating characteristics curve and binary logistic
regression analysis unadjusted and adjusted for known prognostic factors.
Results: In total, 408 patients with M1 or internal carotid artery occlusion were included. The median qTICI was 78
(interquartile range 58–88) and 215 patients (53%) had an eTICI of 2C or higher. qTICI was comparable to eTICI in
predicting favorable outcome with area under receiver operating characteristics curve of 0.63 vs. 0.62 (P¼ 0.8) and 0.87
vs. 0.86 (P¼ 0.87), for the unadjusted and adjusted analysis, respectively. In the adjusted regression analyses, both qTICI
and eTICI were independently associated with functional outcome.
Conclusion: qTICI provides a quantitative measure of reperfusion with similar prognostic value for functional outcome
to eTICI score.
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Introduction
Various grading scales have been introduced to assess
the extent of reperfusion on digital subtraction angiog-
raphy (DSA) images following endovascular treatment
(EVT).1 One of the most frequently used scales is the
modified Treatment in Cerebral Ischemia (mTICI)
scale.2 This scale has been recommended because of
its fair interobserver agreement and clinical prognostic
value.1,3,4 mTICI assesses the proportion of brain tissue
perfused in an antegrade fashion relative to the total
area of the target downstream territory (TDT) distal to
the target occlusion.5 The TDT is the area of the brain
that was supplied by the occluded artery prior to stroke
onset.1 The score ranges from no perfusion (mTICI¼ 0)
to complete reperfusion (mTICI¼ 3). A subsequent
refinement has been made to intermediate grades of
reperfusion (mTICI 2B) to better define successful reper-
fusion.3,4,6 Recently, the extended Thrombolysis in
Cerebral Ischemia (eTICI) scale has been introduced,
which includes grade 2C to account for nearly complete
reperfusion with slow flow in distal cortical vessels or
presence of tiny distal emboli.7–9 This grade 2C has
been retained in the expanded TICI scale, which added
67% perfusion threshold into the middle categories.10
Recent findings suggest that eTICI 2C-3 has a stronger
association with favorable functional outcome than
eTICI 2B-3.10–15
Despite its widespread use, the eTICI score suffers
from two shortcomings: it is prone to observer variance
and it is an ordinal scale.1,6,7,10,16 Moreover, a recent
study showed that reperfusion is generally overesti-
mated by the interventionalist performing EVT com-
pared to core-lab observers.16 An automated and
quantitative reperfusion grading has the potential to
provide a more clinically relevant, less observer-depen-
dent score, and a greater ease of use. In this study, we
present a quantitative reperfusion measure using
semantic segmentation of DSA images. We assessed
the prognostic value of the proposed quantitative reper-
fusion grading for predicting functional outcome in
comparison with eTICI.
Methods
Patients
This is a substudy of the Multicenter Clinical Registry
of Endovascular treatment for acute ischemic stroke in
the Netherlands (MR CLEAN Registry). Details of the
registry, patient inclusion, baseline clinical and imaging
characteristics, and interventional therapy have been
described previously.17 We included only patients with
acute ischemic stroke attributable to an occlusion of the
intracranial internal carotid artery (ICA) or proximal
middle cerebral artery (MCA) (M1) as presented
on DSA who were treated between March 2014 and
June 2016. We also only included patients with
good quality pre- and post-treatment DSA, with full
arterial to venous anteroposterior and lateral runs,
and who were eTICI graded by an independent core-
lab of neuro/interventional radiologists. DSA images
with motion artifacts and low contrast volume were
excluded.
Image analysis
Similar to the eTICI grading, our quantitative reperfu-
sion measure assesses the percentage of the reperfused
area within the TDT on DSA. An overview of the pro-
posed approach is shown in Figure 1.
First, the reperfused area was identified by following
the contrast trajectory past the initial target occlusion.
The contrast trajectory can be roughly divided into
three phases in the brain: the arterial, parenchymal,
and venous phase. This sequence of phases occurs ear-
lier in the proximal part of the intracranial vasculature
than in the distal areas. Since perfusion is only visible
during the parenchymal phase (from contrast opacifica-
tion in the brain microvasculature), segmentation of the
reperfused tissue can be challenging due to the lack of
distinction between phases. This distinction is especially
important to separate the antegrade (via recanalization)
and retrograde (via pial collateral) perfusion as only the
former constitutes reperfusion. Moreover, the local
vessel structure, whether it is artery in earlier frames
or vein in later frames, can be present during the par-
enchymal phase. To accurately assess the extent of
reperfusion in the parenchyma, the vessel structure
was removed from the images.
We quantified reperfusion on a temporal maximum
intensity projection of the images starting at the arterial
until the end of parenchymal phase. The last frame of
parenchymal phase was manually determined as the
immediate frame before the appearance of contrast in
the superior sagittal sinus. We assumed that this frame
marked the separation between antegrade and retro-
grade perfusion.
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We adopted a multiscale vesselness filter to segment
the arteries.18 The vesselness filter detects tubular struc-
tures in images using local curvature information
encoded in a Hessian matrix. Improvements were
made by introducing a normalization factor to the ves-
selness classification to reduce blur surrounding the
vessel. Details can be found in the Online Appendix.
To obtain a parenchymal mask image that contains
only the non-vessel structure, the resulting vessel
mask was subtracted from the original image. This par-
enchymal mask comprised of reperfused area and back-
ground (which includes non-perfused areas). Finally,
the reperfused area was arbitrarily determined as the
area in the parenchymal mask where the pixel intensity
exceeded 7% and 3% of the maximum intensity in the
original image for anteroposterior and lateral runs,
respectively. These numbers reflect the minimum con-
trast intensity in the image that distinguishes perfusion
from background area.
For TDT delineation, an expert observer blinded to
all clinical data except symptomatic side visually
assessed the DSA images of a subpopulation and out-
lined the TDTs. For this study, we included three
expert observers (HP, MK, and BJE) to account for
three different patient subpopulations. The M1 TDT
was defined as the presumed area supplied by the
MCAs including part of lenticulostriate arteries and
holotemporal branch.1 In clinical practice, the ICA
TDT is dependent on the patency of the anterior com-
municating artery. In case the anterior communicating
artery is patent, the ipsilateral anterior cerebral artery
(ACA) territory is usually supplied by the contralateral
anterior circulation. In this case, the ICA TDT is iden-
tical to the M1 TDT. In case of an absent or severely
hypoplastic anterior communicating artery, the ICA
TDT also includes the ACA territory. In practice, base-
line computed tomography angiography (CTA) data
can be used to inspect the patency of the anterior com-
municating artery. However, during the core-lab evalu-
ations of the eTICI, this information was not available
and the M1 TDT was used. Therefore, we used M1
TDT for both ICA and M1 cases in this study. The
effect of using different TDTs for the ICA occlusions
on the quantified TICI (qTICI) score was evaluated.
We did not make a distinction in TDT between a prox-
imal and distal ICA and M1 occlusions since there is no
considerable difference in the TDT. Consensus agree-
ment between expert observers was achieved to
Figure 1. Overview of image segmentation approach in a patient with M1 occlusion. There are two parallel segmentation tasks:
segmentations of reperfused area and of TDT. The reperfused area was segmented from temporal maximum intensity projection
of the images of the arterial and parenchymal phase. The TDTwas defined as the middle cerebral artery territory and was
manually delineated. The percentage of the reperfused area within the TDTwas subsequently calculated.
DSA: digital subtraction angiography; TDT: target downstream territory; TMIP, temporal maximum internsity projection.
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maintain consistency in the delineation process. An
example of a TDT is shown in Figure 1 in the online-
only Data Supplement.
The parenchymal mask within the resulting TDT
was subsequently determined. qTICI was calculated
as the number of pixels of reperfused area in the TDT
divided by the number of pixels in the parenchymal
mask in the TDT and expressed as percentage. The
average qTICI of both anteroposterior and lateral
DSA was used as the final qTICI score.
Angiography evaluation
An independent core-lab assessed all the imaging in the
MR CLEAN Registry.19 The pre- and post-treatment
DSA images were used for reperfusion evaluation with
target occlusion location determined from pre-treat-
ment DSA images. The six-point eTICI grading was
used to adjudicate the reperfusion of the initial target
occlusion. We should clarify that we used the eTICI
and not the expanded TICI definition. The eTICI is
the extension of the modified TICI in which grade 2C
has been added.9 The expanded TICI further divides
the scale 2B into 2B50 and 2B67.10 At the time of the
prospective patient recruitment for the registry, the
expanded TICI was not yet introduced and therefore
not used in the current study. In summary, eTICI 0
describes no reperfusion in TDT; eTICI 1 indicates
antegrade reperfusion past the initial occlusion but
minimal reperfusion of TDT, eTICI 2A is reperfusion
of <50% of TDT, eTICI 2B is a reperfusion of 50%
of TDT, eTICI 2C reflects a near-complete perfusion
with distal slow flow or presence of small cortical
emboli, and eTICI 3 is a complete reperfusion.7
Statistical analyses
Continuous and categorical variables were expressed as
median (interquartile range (IQR)) and frequency
(percentage), respectively. Kruskal–Wallis tests were
performed to compare differences in qTICI scores
between eTICI grades. Functional outcome was deter-
mined by assessing the modified Rankin Scale (mRS)
at day 90 and dichotomized into favorable (mRS 0–2)
and unfavorable outcome (mRS 3–6). Stacked bar
plots were used to visually compare the ordinal mRS
distribution with respect to qTICI and eTICI grades.
A classification table for grouped qTICI based on
the definition of the corresponding eTICI grades was
provided.
The unadjusted and adjusted odds ratios for favor-
able outcome were estimated for qTICI and eTICI using
logistic regression. Adjustments were made by including
major prespecified baseline prognostic factors: age, sex,
baseline stroke severity (National Institutes of Health
Stroke Scale (NIHSS)), Alberta Stroke Program Early
CT Score, CTA collateral score, history of hypertension,
diabetes mellitus, and previous stroke, pre-treatment
mRS, systolic blood pressure, administration of intra-
venous thrombolytics prior to EVT, general anesthesia,
time from onset-to-groin puncture, and duration of
endovascular treatment. For adjusted analyses only,
missing variables were imputed based on additive regres-
sion, bootstrapping, and predictive mean matching using
the aforementioned variables with additional variables:
glucose level, hypercholesterolemia, atrial fibrillation,
history of myocardial infarction, occlusion segment,
time from onset to reperfusion or last contrast bolus,
and NIHSS score after 24 to 48h.19,20 Unadjusted and
adjusted odds ratios were reported with 95% of confi-
dence interval (CI) for statistical precision. Nagelkerke’s
coefficient of determination was used to compare the
unadjusted and adjusted models of qTICI and eTICI
in explaining the proportion of functional outcome vari-
ation. The effect of using different TDTs for ICA occlu-
sion cases in the estimation of the odds ratio was tested
in a sensitivity analysis in which the combined ACA and
MCA TDTs were used instead of the MCA TDT.
The area under the receiver operating characteristic
curve (AUC) was calculated to determine the prognos-
tic value of the logistic regression models in predicting
favorable outcome. P values lower than 0.05 were con-
sidered statistically significant. All statistics were per-
formed using IBM SPSS software (version 19.0.0) and
RStudio, RStudio, Inc. (version 1.2.1335).
Results
A total of 524 patients met the inclusion criteria based
on occlusion location and DSA availability. Based on
DSA quality, 115 additional patients were excluded
because of motion artifacts (N¼ 85) and low contrast
volume (N¼ 30), resulting in a total of 408 patients to
be included in our final analysis (Figure 2 in the online-
only Data Supplement). Table 1 shows the baseline
characteristics of the patients included in this study.
Occlusion sites were ICA in 99 patients and M1 in
309 patients. Median age was 69 (IQR 59 - 78) years
and 43% of patients were female. Median qTICI
score was 78 (IQR 58–88). Core-lab determined
eTICI was 0 in 31 patients (7%), 1 in 7 patients (2%),
2A in 64 patients (16%), 2B in 91 patients (22%), 2C in
56 patients (14%), and 3 in 159 patients (39%).
Figure 2(a) shows the distribution of qTICI values
for different eTICI grades. The qTICI was significantly
different between all eTICI grades (P< 0.001). For ICA
occlusion cases only, the qTICI values were not signifi-
cantly different for eTICI classifications when using the
combined ACA and MCA territories (P¼ 0.28).
The full result of this analysis is shown in Figure 3 in
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Table 1. Baseline characteristics.
N 408
Age, median (IQR) 69 (59–78)
Female sex 200 (43%)
M1 occlusion on DSA 299 (73%)
NIHSS, median (IQR) 16 (12–20)
History of ischemic stroke 67 (17%)
History of hypertension 200 (50%)
History of diabetes mellitus 65 (16%)
Prestroke mRS
0 277 (70%)
1 48 (12%)
2 73 (18%)
Arterial systolic blood pressure in mmHg, median (IQR) 150 (130–165)
Treatment with IV-rtPA 318 (78%)
ASPECTS, median (IQR) 8 (7–10)
CTA collateral score
0 36 (9%)
1 126 (33%)
2 154 (40%)
3 71 (18%)
eTICI
0 28 (8%)
1 7 (2%)
2A 59 (16%)
2B 80 (22%)
2C 48 (13%)
3 141 (39%)
General anesthesia 170 (43%)
Onset-to-groin puncture time in min, median (IQR) 210 (163–260)
EVT time in min, median (IQR) 61 (40–86)
IQR: interquartile range; M1: M1 segment of middle cerebral artery; DSA: digital subtraction angiography; NIHSS: National Institutes of Health Stroke
Scale; mRS: modified Rankin scale; IV-rtPA: intravenous recombinant tissue plasminogen activator; ASPECTS: Alberta Stroke Program Early Computed
Tomography Score; CTA: computed tomography angiography; eTICI: extended thrombolysis in cerebral ischemia; EVT: endovascular treatment.
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the online-only Data Supplement. Figure 2(b) shows
the distribution of mRS for different qTICI groups
and eTICI grades. The group-wise comparison between
qTICI and eTICI is shown in Table 2.
Ninety-five patients had missing baseline prognostic
variables which were imputed for the subsequent pre-
dictive analytics.
Logistic regression analysis showed that both qTICI
and eTICI were significantly associated with favorable
outcome with unadjusted odds ratio of 1.25 (95% CI,
1.14–1.35, P< 0.001) for 10% qTICI increment and of
1.37 (95% CI, 1.2–1.58, P< 0.001) for one grade eTICI
increment (Table 3). After adjustment for baseline
prognostic variables, an increase in 10% point in
qTICI and one grade in eTICI led to the adjusted
odds ratio of 1.28 (95% CI, 1.14–1.42, P< 0.001) and
1.43 (95% CI, 1.18–1.73, P< 0.001), respectively. The
models including qTICI (unadjusted: pseudo-R2¼ 0.08;
adjusted: pseudo-R2¼ 0.50) outperformed the models
including eTICI (unadjusted: pseudo-R2¼ 0.07;
adjusted: pseudo-R2¼ 0.49) in both unadjusted and
adjusted analysis, although the differences were not
statistically significant.
As shown in Figure 3, receiver operator characteris-
tics analysis showed that qTICI and eTICI were mod-
erate predictors of favorable outcome with an AUC of
0.63 (95% CI, 0.58–0.68) vs. 0.62 (95% CI, 0.57–0.67).
For the adjusted model, qTICI and eTICI were com-
parable with AUC 0.87 (95% CI, 0.83–0.90) and 0.86
(95% CI, 0.83–0.90), respectively. For both the
adjusted and unadjusted models, the difference in
AUCs of qTICI and eTICI was not significant
(P¼ 0.87 for the adjusted model, P¼ 0.80 for the unad-
justed model).
The sensitivity analysis showed that the unadjusted
and adjusted odds ratio for 10% qTICI increment were
1.28 (95% CI, 1.16–1.4, P< 0.001) and 1.33 (95% CI,
1.18–1.49, P< 0.001) when the combination of ACA
and MCA territory was used as ICA TDT. These
odds ratios were higher compared to the odds ratios
of qTICI using only MCA territory as the ICA TDT.
Discussion
We have presented a semi-automated quantitative
method to assess reperfusion on DSA images after
endovascular treatment of patients with acute ischemic
stroke due to large vessel occlusion. Our study shows
that in our population, the qTICI is independently
associated with functional outcome. We demonstrated
that qTICI has a similar prognostic value compared
with eTICI. This result remains consistent after the
adjustment for other prognostic factors, indicating
that qTICI could be a potential alternative for
manual reperfusion assessment with a potentially
reduced bias and interobserver variation.
Our method is the first fully quantitative scale of
reperfusion assessment. There have been many iter-
ations of angiographic reperfusion scales: starting
from adopting the Thrombolysis in Myocardial
Infarction scale for the brain, renaming and adjusting
the score to TICI, modifying the threshold for scale 2A
and 2B (from two-thirds to half of the TDT), adding
scale 2C, redefining 2C (90%–99% reperfusion), and
Figure 2. Comparison of qTICI and eTICI. (a) Distribution of the qTICI score for the various eTICI grades. (b) mRS at 90 days
based on qTICI and eTICI.
mRS: modified Rankin Scale; TICI: Thrombolysis in Cerebral Infarction; qTICI: quantified TICI; eTICI: extended TICI.
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expanding scale 2B with the introduction of 2b50 and
2b67.1,7,9,10,21 Each iteration claimed to give a better
definition of successful reperfusion with a more precise
threshold to determine the reperfusion result.4–6,22,23
The inclusion of finer scales was based on evidence
that this provides a better reperfusion assessment and
clinical utility compared to that of coarser scales. This
underpins the potential value of our continuous quan-
titative measure. Additionally, qTICI has minimum
source of bias as the only dependency to the observer
is during the delineation of the TDT. It must be pointed
out that qTICI uses a TDT estimate, which is an actual
TDT with a slight extension to both cranial and caudal
direction. This crude TDT may provide a less accurate
assessment since the actual TDT could differ sig-
nificantly per patient and per occlusion location.
However, qTICI remains significantly associated with
functional outcome. This is likely due to the low sensi-
tivity of qTICI for small TDT differences. Since the
TDT of ICA and M1 occlusion is large, it is expected
Table 2. Classification table of the grouped qTICI and the corresponding eTICI grades.
eTICI 0 eTICI 1 eTICI 2A eTICI 2B eTICI 2C eTICI 3 Total
qTICI 0 2 0 0 0 0 0 2
100% 0% 0% 0% 0% 0% 100%
qTICI 1–9 2 0 0 0 0 0 2
100% 0% 0% 0% 0% 0% 100%
qTICI 10–49 14 5 24 12 2 11 68
21% 7% 35% 18% 3% 16% 100%
qTICI 50–89 11 1 40 65 35 93 245
4.5% 0.5% 16% 27% 14% 38% 100%
qTICI 90–99 2 1 0 12 18 53 86
2% 1% 0% 14% 21% 62% 100%
qTICI 100 0 0 0 2 1 2 5
0% 0% 0% 40% 20% 40% 100%
Total 31 7 64 91 56 159 408
7% 2% 16% 22% 14% 39% 100%
TICI: Thrombolysis in Cerebral Infarction; qTICI: quantified TICI; eTICI: extended TICI. The correct classifications are in bold.
Table 3. Results of unadjusted and adjusted regression analysis for the effect of reperfusion score on the dichotomized functional
outcome.
Unadjusted Adjusteda
uOR (95% CI) P Pseudo-R2 aOR (95% CI) P Pseudo-R2
qTICI per 10% 1.28 (1.14–1.42) <0.001 0.08 1.25 (1.14–1.35) <0.001 0.50
eTICI per grade 1.37 (1.2–1.58) <0.001 0.07 1.43 (1.18–1.73) <0.001 0.49
Note: Higher Pseudo-R2 implies better models. TICI: Thrombolysis in Cerebral Infarction; qTICI: quantified TICI; eTICI: extended TICI; uOR:
unadjusted odds ratio; aOR: adjusted odds ratio; CI: confidence interval; Pseudo-R2: Nagelkerke’s coefficient of determination.
aAdjusting for sex, age, NIHSS baseline, Alberta Stroke Program Early CT Score baseline, CTA collateral score, previous ischemic stroke, previous
hypertension, previous diabetes mellitus, prestroke mRS, arterial systolic blood pressure, treatment with intravenous recombinant tissue plasminogen
activator, general anesthesia, onset-to-groin puncture time, and EVT time.
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that minor variation in TDT delineation results in small
effects in the qTICI score. In addition, the crude TDT
increases the ease of use as meticulous delineation of
TDT is not necessary. This could be beneficial in pro-
viding a robust reperfusion assessment especially on a
large data set of clinical trials and registries. It also
allows for faster assessment of difficult cases because
of anatomical variation or DSA overprojection.
qTICI and eTICI behave differently in cases with
failure of recanalization but retrograde reperfusion
via collaterals. Here, some patients have high qTICI,
whereas their reperfusion were classified as eTICI 0.
For these cases, the high qTICI score may have
included a substantial amount of retrograde filling
from collaterals in the TDT, which is not included in
the eTICI grading. While this may subvert qTICI value
in assessing poor reperfusion, the true utility of qTICI
is at assessing moderate to high reperfusion. It has been
postulated that a fast retrograde perfusion may provide
sufficient sustenance to the oligemic region and thus its
inclusion may be of added value, though eventual
watershed infarcts have also been described in these
cases.24,25 The actual benefit of the inclusion of retro-
grade perfusion in the assessment was not studied.
Another discrepancy between qTICI and eTICI stems
from the different concern regarding vessel patency.
In recanalized patients with severe stroke or a damaged
blood–brain barrier, qTICI may confuse the
extravasation of contrast near the artery as parenchy-
mal blush thus exaggerating the rate of reperfusion.
Further study is required to confirm the extent of this
effect. Finally, Table 2 shows that the grouped qTICI
and eTICI only have a modest agreement. This could
be attributed to different factors according to the
degree of the reperfusion: for moderate reperfusion, a
large mismatch between the crude TDT and the actual
TDT and for zero or complete reperfusion, the hyper-
sensitivity of qTICI to TDT. Overall, grouping of
qTICI based on the corresponding eTICI grades, espe-
cially qTICI 1 (eTICI 1) and qTICI 99 (eTICI 2C), was
somewhat arbitrary and has minimum parallel to the
clinical practice of eTICI grading. Hence, the group-
wise comparison should be interpreted with caution.
It was demonstrated that the reperfusion scores by
themselves have limited value in predicting functional
outcome. This is illustrated by the modest predictive
value of both qTICI and eTICI. Similar analyses
performed on the adjusted models with either qTICI
or eTICI show stronger predictive value, where these
models explain about half of the variance. This suggests
that in a population where most of the patients
achieve successful reperfusion, the reperfusion measure
becomes a non-variable and has limited effect on func-
tional outcome prediction. However, it should be noted
that in both these models, the perfusion scores are inde-
pendently associated with outcome. The huge effect of
Figure 3. Receiver operating characteristic curves for qTICI and eTICI for predicting good functional outcome (mRS 0–2). Left:
The area under the curve for qTICI and eTICI as a single predictor were 0.63 and 0.62, respectively. Right: The area under the
curve for adjusted predictive model with either qTICI or eTICI were 0.87 and 0.86, respectively, a minor improvement from the
area under the curve 0.85 of the model with the other prognostic factors.
TICI: Thrombolysis in Cerebral Infarction; qTICI: quantified TICI; eTICI: extended TICI.
International Journal of Stroke, 0(0)
8 International Journal of Stroke 0(0)
endovascular treatment in recent trials has shown that
the procedural outcome of endovascular treatment is
important.17,19,26,27 This confirms that although reper-
fusion outcome may play a substantial role, functional
outcome is multifactorial.
The limitations of our study include the availability
of adequate images. qTICI is sensitive to noise; motion
artifacts could result in false-positive identification of
reperfused tissue. A full frontal and lateral view of the
affected hemisphere were required, and this was not
available for all patients. Another requirement for
images includes the first passage of contrast as later
passages may be detrimental to the assessment accur-
acy. We also limited our patient inclusion to only ICA
and M1 occlusions as the TDT variation was expected
to be minimal.
Our method may benefit from an automatic delinea-
tion of TDT, entirely eliminating observer dependency.
To complete the full spectrum of perfusion assessment,
cases with more distal occlusion could be included.
The high variability of TDT for distal occlusions, how-
ever, is a challenge for automated methods. Another
potential improvement would be to incorporate a
region-weighted score. It has been reported that infarct
location, especially in the pre-central sulcus and central
sulcus, is associated with functional outcome.28
Therefore, if implemented, qTICI may have an
improved prognostic value as the perfusion is weighted
based on the importance of the territory.
Conclusion
We developed a quantitative and semi-automated
reperfusion score for endovascular treatment evalu-
ation of patients with acute ischemic stroke due to a
large vessel occlusion. We have shown that qTICI is an
independent predictor of functional outcome and has
similar prognostic value as the standard eTICI. The use
of crude TDT in qTICI potentially minimizes observer
variations and allows more robust assessment across
large imaging data set, making qTICI valuable for
reperfusion assessment in clinical trial or registry.
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